Price target upside
Amneal Pharmaceuticals, Inc. - Class A Common Stock Price Target Upside or Downside
AMRX price target upside based on the current price and analyst average.
Direct answer
Amneal Pharmaceuticals, Inc. - Class A Common Stock's analyst target implies +17.5%.
The average target is $20.75 compared with a recorded current price of $17.66.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 13, 2026.
Get free Amneal Pharmaceuticals, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $17.66
- Average price target
- $20.75
- High price target
- $25.00
- Low price target
- $16.00
- Target upside
- +17.5%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026